- 2022 - 2025 新規メカノストレス因子による筋疾患への治療介入およびQOL維持への貢献
- 2022 - 2025 Investigation of gene expression in pulmonary atresia and intact ventricular septum
- 2021 - 2024 心筋内炎症の鍵となる介在板分子は拡張型心筋症の予後を規定するか?
- 2020 - 2023 非侵襲的検体を用いたミトコンドリア心筋症の新規診断法の確立
- 2019 - 2022 Development of atropine esterase formulation to improve the effect of atropine used in the anesthesiology field
- 2018 - 2021 Development and clinical application of low molecular chemicals that modulate myosin light chain kinase for the treatment of heart failure with preserved ejection fraction
- 2015 - 2019 Identification of novel factor in hereditary sinus bradycardia and its application to preventive medicine
- 2015 - 2018 The role of myosin regulatory light chain phosphorylation in heart diseases
- 2013 - 2016 Molecular pathology of moyamoyta disease and its translational research toward prevention and drug development
- 2012 - 2015 Development of new heart failure treatment using DPP-4 inhibitors-The role of adenosine
- 2012 - 2015 Cardiac Myosin Light Chain Kinase Mutation as a Cause of Cardiomyopathies
- 2010 - 2012 The elucidation of mechanisms for myseterin and its susceptibility variant and development of prevention program for moyamoya disease.
- 2010 - 2012 Identification and functional analysis of the factors that interact with cardiac protective factor HB-EGF
- 2009 - 2011 Research for the elucidation of the cardiovascular effect and application to treatment by adenosine
- 2008 - 2010 Identification and Functional Analysis of Cardiac Specific Singling Molecules and Therapeutic Applications for Cardiovascular Disease
- 2004 - 2005 常染色体優性開放隅角緑内障GLC1Dの原因遺伝子の同定
Show all